Skip to main content
. 2020 Feb 20;5(1):29–33. doi: 10.1136/svn-2019-000274

Table 1.

Direct-acting oral anticoagulants (DOACs) and reversal

DOAC Brand name Mechanism of action Time to onset t1/2 Reversal
Dabigatran Pradaxa Direct thrombin inhibitor 0.5–2 hour 15 hours Idarucizumab
Rivaroxaban Xarelto Factor Xa inhibitor 2–4 hour 6–12 hour 3F- and 4F-PCC, andexanet alfa
Apixaban Eliquis 1–2 hour
Edoxaban Savaysa, Lixiana 1–2 hour Andexanet alfa
Betrixaban Bevyxxa 3–4 hour 24 hours